Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.